Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Chitosan on the Production of Th1 and Th2 Cytokines in Mice

키토산이 Th1과 Th2 사이토카인 생성에 미치는 효과

  • Kim, Kwang-Hyuk (Department of Microbiology, Institute for Medicine, Kosin University College of Medicine)
  • 김광혁 (고신대학교 의과대학 의과학연구소, 미생물학교실)
  • Published : 2009.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Chitosan is derived from chitin by a process of controlled deacetylation. In the present study, we investigated the effects of chitosan on the production of cytokines such as interleukin-2 (IL-2), interferon-$\gamma$ (IFN-$\gamma$), interleukin-4 (IL-4), and interleukin-10 (IL-10) in mice. The culture supernatants of splenocytes exposed with chitosan alone or chitosan plus cell stimulants, lipopolysaccharide (LPS), concanavalin A (Con A), and phytohemagglutinin-P (PHA-P) were harvested to assay IL-2, IFN-$\gamma$, IL-4, and IL-10 production. IL-2, IFN-$\gamma$, and IL-4 from splenocytes exposed to chitosan showed a greater increase compared to the PBS control group. IL-2 and IFN-$\gamma$ levels in the culture supernatants from splenocytes exposed to LPS+chitosan were higher than those of the groups exposed to LPS alone. IL-4 and IL-10 levels in the culture supernatants from splenocytes exposed to LPS+chitosan were lower than those of the groups exposed to LPS only. These findings demonstrate that chitosan upregulates the immune responses by Th1 cytokines (IL-2 and IFN-$\gamma$) and downregulates those by Th2 cytokines (IL-4 and IL-10) in LPS-associated immunity. These results show the potential of its usefulness for balancing the Th1/Th2 immune response, if more research results were accumulated.

본 연구에서는 키토산이 마우스에서 Th1과 Th2 사이토카인의 생성에 미치는 효과를 보기 위하여 키토산에 의한 IL-2 생성의 변화, 키토산에 의한 IFN-$\gamma$ 생성의 변화, 그리고 키토산에 의한 IL-4 생성의 변화, 키토산에 의한 IL-10 생성의 변화를 시험관내에서 시험하였다. 또한 LPS, Con A, PHA-P와 같은 세포자극물과 키토산이 함께 작용되었을 때 상기 사이토카인의 생성의 변화를 관찰하였다. 키토산을 비장세포에 노출시켰을 때 Th1 사이토카인인 IL-2와 IFN-$\gamma$의 생성이 크게 증가하였지만 고농도의 키토산에 의해서는 오히려 대조군에 비하여 감소하였다. LPS와 같은 세균독소, Con A와 같은 세포자극물을 비장세포에 노출시켰을 때 IL-2와 IFN-$\gamma$의 생성은 큰 상승을 나타냈으며 LPS의 경우 키토산에 의해서 IL-2와 IFN-$\gamma$의 생성이 증폭되었다. 키토산을 비장세포에 노출시켰을 때 Th2 사이토카인인 IL-4와 IL-10의 생성은 큰 증가를 보이지 않았다. LPS와 같은 세균독소에 의한 IL-4와 IL-10의 상승이 키토산에 의해서 억제되었다. 따라서 이러한 결과들로 부터 키토산이 LPS와 같은 세균독소가 존재하는 가운데 Th1 사이토카인을 증가시키고 Th2 사이토카인을 감소시킴에 따른 면역반응 환경이 이루어질 가능성이 높다 하겠다. 앞으로 키토산에 대한 더 많은 자료의 축적이 이루어지게 되면 임상에서 Th1/Th2 면역반응의 균형을 유지하는데 이용될 가능성도 있다 하겠다.

Keywords

References

  1. Akbuga, J., S. Ozbas-Turan, and N. Erdogan. 2004. Plasmid- DNA loaded chitosan microspheres for in vitro IL-2 expression. Eur. J. Pharm. Biopharm. 58, 501-507 https://doi.org/10.1016/j.ejpb.2004.04.015
  2. Baek, K. S., E. K. Won, and S. Y. Choung. 2007. Effects of chitosan on serumcytokine levels in elderly subjects. Arch. Pharm. Res. 30, 1550-1507 https://doi.org/10.1007/BF02977324
  3. Chen, W. R., H. Liu, J. W. Ritchey, K. E. Bartels, M. D. Lucroy, and R. E. Nordquist. 2002. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. Cancer Res. 62, 4295-4299
  4. Chung, Y. S., K. H. Kim, Y. K. Jeong, and M. W. Chang. 2004. Effects of chitosan on anti-tumor activity in mice. J. Life Sci. 14, 209-214 https://doi.org/10.5352/JLS.2004.14.2.209
  5. Eroglu, M., S. Irmak, A. Acar, and E. B. Denkbas. 2002. Design and evaluation of a mucoadhesive therapeutic agent delivery system for postoperative chemotherapy in superficial bladder cancer. Int. J. Pharm. 235, 51-59 https://doi.org/10.1016/S0378-5173(01)00979-6
  6. Howling, G. I., P. W. Dettmar, P. A. Goddard, F. C. Hampson, M. Dornish, and E. J. Wood. 2001. The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro. Biomaterials 22, 2959-2966 https://doi.org/10.1016/S0142-9612(01)00042-4
  7. Iqbal, M., W. Lin, I. Jabbal-Gill, S. S. Davis, M. W. Steward, and L. Illum. 2002. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Article in press. Vaccine 3585, 1-8
  8. Kato, Y., H. Onishi, and Y. Machida. 2002. Efficacy of lactosaminated and intact N-succinyl-chitosan-mitomycin C conjugates against M5076 liver metastatic cancer. J. Pharm. Pharmacol. 54, 529-537 https://doi.org/10.1211/0022357021778646
  9. Kato, Y., H. Onishi, and Y. Machida. 2001. Lactosaminated and intact N-succinyl-chitosans as drug carriers in liver metastasis. Int. J. Pharm. 226, 93-106 https://doi.org/10.1016/S0378-5173(01)00777-3
  10. Kimura, Y. and H. Okuda. 1999. Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice. Jpn. J. Cancer Res. 90, 765-774 https://doi.org/10.1111/j.1349-7006.1999.tb00813.x
  11. Kimura, Y., N. Sawai, and H. Okuda. 2001. Antitumor activity and adverse reactions of combined treatment with chitosan and doxorubicin in tumor-bearing mice. J. Pharmacol. 53, 1373-1378 https://doi.org/10.1211/0022357011777873
  12. Koide, S. S. 1998. Chitin-chitosan: properties, benefits, and risks. Nutrition Res. 18, 1091-1101 https://doi.org/10.1016/S0271-5317(98)00091-8
  13. Li, H., R. Gao, M. Wu, M. Fu, K. Wu, Y. Yang, X. Wang, Z. Wang, and S. Liu. 2004. Effects of entrapment of murine interleukin-2 gene with chitosan nanoparticles on expression of mIL-2 gene and on regulation of immune response in mice. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 21, 947-952
  14. McNeela, E. A., D. O'Connor, I. Jabbal-Gill, L. Illum, S. S. Davis, M. Pizza, S. Peppoloni, R. Rappuoli, and K. H. Mills. 2000. A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responsesfollowing nasal delivery. Vaccine 19, 1188-1198 https://doi.org/10.1016/S0264-410X(00)00309-1
  15. Mire-Sluis, A. R. and R. Thorpe. 1998. CYTOKINES. pp. 19-400, Academic Press. San Diego, California
  16. Pae, H. O., W. G. Seo, N. Y. Kim, G. S. Oh, G. E. Kim, Y. H. Kim, H. J. Kwak, Y. G. Yun, C. D. Jun, and H. T. Chung. 2001. Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer. Leuk. Res. 25, 339-346 https://doi.org/10.1016/S0145-2126(00)00138-7
  17. Peluso, G., O. Petillo, M. Ranieri, M. Santin, L. Ambrosio, D. Calabro, B. Avallone, and G. Balsamo. 1994. Chitosanmediated stimulation of macrophage function. Biomaterials 15, 1215-1220 https://doi.org/10.1016/0142-9612(94)90272-0
  18. Seferian, P. G. and M. L. Martinez. 2001. Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine 19, 661-668 https://doi.org/10.1016/S0264-410X(00)00248-6
  19. Shikata, F., H. Tokumitsu, H. Ichikawa, and Y. Fukumori. 2002. In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur. J. Pharm. Biopharm. 53, 57-63 https://doi.org/10.1016/S0939-6411(01)00198-9
  20. Takashi, M., O. Masahiro, M. Mitsunobu, U. Keisuke, T. Seiichi, O. Yoshiharu, M. Sabro, and F. Toru. 1997. Effect of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro. Biomaterials 18, 947-951 https://doi.org/10.1016/S0142-9612(97)00017-3
  21. Ueno, H., T. Mori, and T. Fujinaga. 2001. Topical formulation and wound healing applications of chitosan. Adv. Drug Deliv. Rev. 52, 105-115 https://doi.org/10.1016/S0169-409X(01)00189-2
  22. van der Lubben, I. M., G. Kersten, M. M. Fretz, C. Beuvery, J. C. Verhoef, and H. E. Junginger. 2002. Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Article in press. Vaccine 3600, 1-9
  23. van der Lubben, I. M., J. C. Verhoef, G. Borchard, and H. E. Junginger. 2001. Chitosan for mucosal vaccination. 2001. Adv. Drug Deliv. Rev. 52, 139-144 https://doi.org/10.1016/S0169-409X(01)00197-1
  24. Westerink, M. A. J., S. L. Smithson, N. Srivastava, J. Blonder, C. Coeshott, and G. J. Rosenthal. 2002. ProJuvant (Pluronic F127 /chitosan) enhances the immune response to intranasally administered tetanus toxoid. Vaccine 20, 711-723 https://doi.org/10.1016/S0264-410X(01)00423-6
  25. Wu, K. Y., M. Wu, M. L. Fu, H. Li, Y. Yang, H. Zhang, C. Cheng, Z. Z. Wang, X. Y. Wang, X. B. Lu, D. G. Liu, H. Li, and R. Gao. 2006. A novel chitosan CpG nanoparticle regulates cellular and humoral immunity of mice. Biomed. Environ. Sci. 19, 87-95
  26. Xie, Y., N. J. Zhou, S. Y. Xiong, J. Chen, Y. F. Gong, N. H. Lu, and C. W. Wang. 2007. Anti-helicobacter pylori effect and regulation of T helper response of chitosan. Zhonghua Nei Ke Za Zhi 46, 220-223
  27. Xie, Y., N. J. Zhou, Y. F. Gong, X. J. Zhou, J. Chen, S. J. Hu, N. H. Lu, and X. H. Hou. 2007. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection. World J. Gastroenterol. 13, 1547-1553 https://doi.org/10.3748/wjg.v13.i10.1547
  28. Yermak, I. M., V. N. Davidova, V. I. Gorvach, P. A. Luk'yanov, T. F. Solov'eva, A. J. Buwitt-Beckman U, E. T. Rietschel, and Y. S. Ovodov. 2005. Forming and immunological properties of some lipopolysaccharide-chitosan complexes. Biochimie 88, 23-30 https://doi.org/10.1016/j.biochi.2005.07.004

Cited by

  1. Inflammatory Bowel Disease and Cytokine vol.23, pp.3, 2013, https://doi.org/10.5352/JLS.2013.23.3.448